Malignant Somatostatinoma
1 clinical trials · Condition
◉ Watch Malignant Somatostatinoma
| Record | Firm | Date |
|---|---|---|
| Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor (NCT02831179) | Vanderbilt-Ingram Cancer Center | 2017-12-01 |
Track Malignant Somatostatinoma automatically
Every clearance here is in the API, with alerts when new ones post.